COMPOSTOS DERIVADOS SUBSTITUÍDOS DE IMIDAZOPIRIDINA E COMPOSIÇÃO FARMACÊUTICA CONTENDO OS MESMOS

The present invention relates to substituted imidazopyridine derivatives as melanocortin-4 receptor (MC-4R) modulators, in particular as melanocortin 4 receptor antagonists. The antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, anxi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MIROSLAV TERINEK, GUENTHER METZ, ACHIM FEURER, HERVE SIENDT, CESARE MONDADORI, ULRICH ABEL, HOLGER HERZNER, CHRISTIAN RUMMEY, HOLGER DEPPE, BARBARA HOFFMANN-ENGER, SONJA NORDHOFF, INGE OTT, MICHAEL SOEBERDT, PHILIPP WEYERMANN, MARCO HENNEBOEHLE
Format:	Patent
Sprache:	por
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to substituted imidazopyridine derivatives as melanocortin-4 receptor (MC-4R) modulators, in particular as melanocortin 4 receptor antagonists. The antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, anxiety and depression.